Annual Total Expenses
$25.46 M
-$3.07 M-10.77%
31 December 2023
Summary:
Chemomab Therapeutics annual total expenses is currently $25.46 million, with the most recent change of -$3.07 million (-10.77%) on 31 December 2023. During the last 3 years, it has risen by +$19.49 million (+326.31%). CMMB annual total expenses is now -10.77% below its all-time high of $28.53 million, reached on 31 December 2022.CMMB Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$3.71 M
-$58.00 K-1.54%
01 September 2024
Summary:
Chemomab Therapeutics quarterly total expenses is currently $3.71 million, with the most recent change of -$58.00 thousand (-1.54%) on 01 September 2024. Over the past year, it has dropped by -$657.00 thousand (-15.04%). CMMB quarterly total expenses is now -59.00% below its all-time high of $9.05 million, reached on 31 March 2023.CMMB Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CMMB Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.8% | -15.0% |
| 3 y3 years | +326.3% | +28.3% |
| 5 y5 years | - | - |
CMMB Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -10.8% | +326.3% | -59.0% | +28.3% |
| 5 y | 5 years | -10.8% | +326.3% | -59.0% | +237.0% |
| alltime | all time | -10.8% | +326.3% | -59.0% | +237.0% |
Chemomab Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.71 M(-1.5%) |
| June 2024 | - | $3.77 M(-6.9%) |
| Mar 2024 | - | $4.05 M(+5.2%) |
| Dec 2023 | $25.46 M(-10.8%) | $3.85 M(-11.9%) |
| Sept 2023 | - | $4.37 M(-46.7%) |
| June 2023 | - | $8.20 M(-9.4%) |
| Mar 2023 | - | $9.05 M(+4.7%) |
| Dec 2022 | $28.53 M | $8.64 M(+3.9%) |
| Sept 2022 | - | $8.32 M(+33.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $6.25 M(+17.6%) |
| Mar 2022 | - | $5.32 M(+5.9%) |
| Dec 2021 | $12.37 M(+107.1%) | $5.02 M(+73.8%) |
| Sept 2021 | - | $2.89 M(+5.0%) |
| June 2021 | - | $2.75 M(+62.0%) |
| Mar 2021 | - | $1.70 M(-12.5%) |
| Dec 2020 | $5.97 M | $1.94 M(+58.5%) |
| Sept 2020 | - | $1.23 M(+11.3%) |
| June 2020 | - | $1.10 M(-35.4%) |
| Mar 2020 | - | $1.70 M |
FAQ
- What is Chemomab Therapeutics annual total expenses?
- What is the all time high annual total expenses for Chemomab Therapeutics?
- What is Chemomab Therapeutics annual total expenses year-on-year change?
- What is Chemomab Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Chemomab Therapeutics?
- What is Chemomab Therapeutics quarterly total expenses year-on-year change?
What is Chemomab Therapeutics annual total expenses?
The current annual total expenses of CMMB is $25.46 M
What is the all time high annual total expenses for Chemomab Therapeutics?
Chemomab Therapeutics all-time high annual total expenses is $28.53 M
What is Chemomab Therapeutics annual total expenses year-on-year change?
Over the past year, CMMB annual total expenses has changed by -$3.07 M (-10.77%)
What is Chemomab Therapeutics quarterly total expenses?
The current quarterly total expenses of CMMB is $3.71 M
What is the all time high quarterly total expenses for Chemomab Therapeutics?
Chemomab Therapeutics all-time high quarterly total expenses is $9.05 M
What is Chemomab Therapeutics quarterly total expenses year-on-year change?
Over the past year, CMMB quarterly total expenses has changed by -$657.00 K (-15.04%)